MEDICAL PROPERTIES TRUST INC
MPTMedical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net leases, in which tenants pay rent as well as the maintenance costs and property taxes usually handled by lessors. These lease types, common among REITs, are often seen by prospective tenants as a source of cash infusion which can allow them to avert bankruptcy, pay debts, or improve their properties.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
No drugs found in this phase.
Frequently asked questions
When is MEDICAL PROPERTIES TRUST INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for MEDICAL PROPERTIES TRUST INC (MPT) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track MPT biotech catalysts?→
Add MPT to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow MEDICAL PROPERTIES TRUST INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.